Search Press releases

Press releases teaser image
16 Oct 2026

UCB announces U.S. FDA approval for ZILBRYSQ[®] (zilucoplan) autoinjector self-administration for adults living with generalized myasthenia gravis

Read More
Press releases teaser image
30 Sep 2026

UCB announces new data at EADV 2026 supporting earlier use of BIMZELX[®] (bimekizumab) for treating hidradenitis suppurativa

Read More
Press releases teaser image
30 Sep 2026

UCB announces new data at EADV 2026 supporting earlier use of BIMZELX[®] (bimekizumab) for treating hidradenitis suppurativa

Read More
Press releases teaser image
29 Sep 2026

UCB data presented at 2026 AANEM Annual Meeting and MGFA Scientific Session underscore leadership in advancing targeted treatments for gMG

Read More
Press releases teaser image
9 Sep 2026

UCB receives U.S. FDA Breakthrough Therapy Designation for CIMZIA[®] (certolizumab pegol) in pregnant women with antiphospholipid syndrome (APS)

Read More
Press releases teaser image
8 Sep 2026

UCB opens ‘Expressing Epilepsy’ art exhibition featuring acclaimed artists living with epilepsy

Read More

Stay up-to-date on the latest news and information from UCB

Subscribe